Engineered Regeneration (ER) is a peer reviewed, fully Open Access journal that advances the biomedical field with cutting-edge research and applications on all aspects of tissue growth, regeneration, and repair. This multidisciplinary preeminent journal brings together the principles of engineering and life sciences in engineering-driven medicine. The journal provides a central forum for groundbreaking scientific research and developments of clinical applications that will contribute to the ultimate care of patients.

ER focuses on the convergence of life sciences, engineering and medicine to better understand and treat human diseases more effectively. The journal publishes original research papers, reviews, short communications and perspective papers on the development of therapeutic approaches for tissue regeneration, cancer and other human diseases. Studies involving stem/progenitor cells, biomaterials and scaffolds, drug/gene delivery, as well as controlled releases of growth factors and other bioactive agents are particularly encouraged. All submissions will undergo rigorous peer review to ensure high quality and standard.